These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 31893932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K.
    Cochrane Database Syst Rev; 2020 Nov 09; 11(11):CD005613. PubMed ID: 33166419
    [Abstract] [Full Text] [Related]

  • 4. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B, Metzendorf MI, Richter B.
    Cochrane Database Syst Rev; 2021 Mar 04; 3(3):CD013498. PubMed ID: 33662147
    [Abstract] [Full Text] [Related]

  • 5. Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics.
    Fishel Bartal M, Ward C, Refuerzo JS, Ashimi SS, Joycelyn CA, Chen HY, Chauhan SP, Sibai BM.
    Am J Perinatol; 2020 Jan 04; 37(1):30-36. PubMed ID: 31430822
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM, Rosenn BM, Foroutan J, Bimson BE, Al Ibraheemi Z, Moshier EL, Brustman LE.
    Am J Obstet Gynecol; 2015 Sep 04; 213(3):426.e1-7. PubMed ID: 26070699
    [Abstract] [Full Text] [Related]

  • 7. Comparative effectiveness and safety of different basal insulins in a real-world setting.
    Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D, Zhou Z, Gao Y, Garg SK, Pan C, Weng J, Paul SK, ORBIT study group.
    Diabetes Obes Metab; 2017 Aug 04; 19(8):1116-1126. PubMed ID: 28230322
    [Abstract] [Full Text] [Related]

  • 8. Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.
    Rys P, Wojciechowski P, Rogoz-Sitek A, Niesyczyński G, Lis J, Syta A, Malecki MT.
    Acta Diabetol; 2015 Aug 04; 52(4):649-62. PubMed ID: 25585592
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.
    Haukka J, Hoti F, Erästö P, Saukkonen T, Mäkimattila S, Korhonen P.
    Pharmacoepidemiol Drug Saf; 2013 Dec 04; 22(12):1326-35. PubMed ID: 24150837
    [Abstract] [Full Text] [Related]

  • 10. Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults.
    Strandberg AY, Khanfir H, Mäkimattila S, Saukkonen T, Strandberg TE, Hoti F.
    Ann Med; 2017 Jun 04; 49(4):357-364. PubMed ID: 28042719
    [Abstract] [Full Text] [Related]

  • 11. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.
    Clin Ther; 2004 May 04; 26(5):724-36. PubMed ID: 15220016
    [Abstract] [Full Text] [Related]

  • 12. Comparison of treatment with insulin detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes. A retrospective study.
    Kazakou P, Paschou SA, Mitropoulou M, Vasileiou V, Sarantopoulou V, Anastasiou E.
    Hormones (Athens); 2023 Dec 04; 22(4):695-701. PubMed ID: 37775682
    [Abstract] [Full Text] [Related]

  • 13. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
    Johansen OE, Vanberg PJ, Kilhovd BK, Jørgensen AP.
    Vasc Health Risk Manag; 2009 Dec 04; 5(1):121-8. PubMed ID: 19436668
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
    Zhang T, Lin M, Li W, Fan X, Du T, Zhao Y, Zhang X.
    Adv Ther; 2016 Feb 04; 33(2):178-85. PubMed ID: 26809253
    [Abstract] [Full Text] [Related]

  • 15. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.
    Clin Ther; 2008 Aug 04; 30(8):1476-84. PubMed ID: 18803989
    [Abstract] [Full Text] [Related]

  • 16. Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors.
    Zhang T, Ji L, Gao Y, Zhang P, Zhu D, Li X, Ji J, Zhao F, Zhang H, Guo X.
    Diabetes Technol Ther; 2017 Nov 04; 19(11):675-684. PubMed ID: 29090977
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T, Philotheou A, Goldman D, Guo X, Ping L, Cali A, Johnston P.
    Pediatr Diabetes; 2013 Dec 04; 14(8):593-601. PubMed ID: 23730996
    [Abstract] [Full Text] [Related]

  • 18. Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
    Polonsky W, Traylor L, Gao L, Wei W, Ameer B, Stuhr A, Vlajnic A.
    J Diabetes Complications; 2017 Mar 04; 31(3):562-568. PubMed ID: 28040350
    [Abstract] [Full Text] [Related]

  • 19. Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial.
    Fishel Bartal M, Ward C, Blackwell SC, Ashby Cornthwaite JA, Zhang C, Refuerzo JS, Pedroza C, Lee KH, Chauhan SP, Sibai BM.
    Am J Obstet Gynecol; 2021 Jul 04; 225(1):87.e1-87.e10. PubMed ID: 33865836
    [Abstract] [Full Text] [Related]

  • 20. Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins.
    Bradley MC, Chillarige Y, Lee H, Wu X, Parulekar S, Wernecke M, Bright P, Soukup M, MaCurdy TE, Kelman JA, Graham DJ.
    Diabetes Care; 2020 Apr 04; 43(4):785-792. PubMed ID: 32075848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.